GlobeStar Therapeutics (GSTC) Short Interest Ratio & Short Volume

Short interest is the volume of GlobeStar Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 336,400 shares of GSTC short. Learn More on GlobeStar Therapeutics' current short interest.

GlobeStar Therapeutics saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 336,400 shares, an increase of 146.1% from the previous total of 136,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to GlobeStar Therapeutics: Sonnet BioTherapeutics Holdings, Inc. (5.06%), ASLAN Pharmaceuticals Limited (1.40%), SQZ Biotechnologies (0.08%), Emmaus Life Sciences, Inc. (0.00%), Kaya Holdings, Inc. (0.00%), International Stem Cell Co. (0.04%), Biodexa Pharmaceuticals Plc (43.70%), GLG Life Tech Co. (0.00%), NexImmune, Inc. (1.39%), PainReform Ltd. (9.33%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

Short selling GSTC is an investing strategy that aims to generate trading profit from GlobeStar Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for GlobeStar Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GSTC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GSTC, twice per month. The most recent reporting period available is October, 31 2024.